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This year marks the 30th anniversary
of an important milestone in the history of
biology: the dawn of the genomics era with
the first report of the complete DNA se-
quence of a viral genome in 1977.
Viruses are submicroscopic micro-or-
ganisms that are dwarfed in size and com-
plexity by all free-living forms of life.
Thus, when rudimentary methods for deter-
mining short stretches of DNA sequence
were developed in the 1970s, a few vision-
ary laboratories realized that viral genomes
should be the target of the first large-scale
sequencing efforts. The results of this en-
deavor were eagerly awaited. An entire
page of the 1970 edition of Albert
Lehninger’s Biochemistry, then the stan-
dard text in the field, was devoted to the
imaginary DNA sequence of a bacterial
virus, the bacteriophage φX174.
At the time, the prospect of sequencing
the vastly larger human genome seemed
impossible. Nevertheless, the sequencing
of viral genomes provided seminal insights
not only into viral growth, but also into an-
imal and human carcinogenesis. These
studies resulted in the discovery of cellular
oncogenes and led directly to the identifica-
tion of viruses as an important cause of
human cancer and the idea that non-viral
cancer is, in large part, a genetic disease.
In addition, the sequence analysis of viral
genomes laid the intellectual and technical
framework that enabled the eventual se-
quencing and analysis of cellular genomes,
an effort that in turn is unlocking many of
the secrets of cancer and providing new op-
portunities for more effective cancer treat-
ments.
SETTING THE STAGE
The breakthrough that allowed the se-
quencing of viral genomes (and later, larger
cloned genomes) was the use of restriction
endonucleases to manipulate and analyze
DNA. Bacterial cells synthesize restriction
enzymes to defend themselves against in-
vading foreign DNA, and these enzymes
were first identified and characterized on
the basis of their ability to cleave bacterio-
phage DNA.
Thevalueofrestrictionenzymeswases-
tablished by a series of pioneering studies by
Daniel Nathans at Johns Hopkins and Paul
Berg at Stanford on the genome of SV40, a
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daniel.dimaio@yale.edu.small virus that normally infects monkeys.
SV40wasdiscoveredintissueculturesofmon-
key kidney cells in which poliovirus vaccine
was produced, and many vaccinated individu-
als were inadvertently inoculated with SV40
duringearlypoliovirus vaccination programs.
Enhanced interest in SV40 lay in the
fact that it and the closely related mouse
polyomavirus caused tumors in rodents. It
was hoped that detailed analysis of tumor
viruses would shed light on the genesis of
common human cancers and suggest new
approaches to prevent and treat cancer.
This hope has been realized many times
over. SV40 has been implicated in some
human cancers, including childhood brain
tumors, mesotheliomas, and non-Hodgkins
lymphoma, but an etiologic role of SV40 in
these tumors has not been established un-
equivocally [1]. Nevertheless, the early de-
velopment of molecular biology techniques
to analyze SV40 DNAled to the first restric-
tion map and the first localization of a ge-
netic signal, the viral origin of DNA
replication, in eukaryotic cells [2-4].
The first recombinant DNA molecule
constructed in vitro consisted of SV40
linked to bacteriophage lambda DNA[5].
This work set the stage for much of
modern genetics and molecular biology and
won Nobel prizes for Nathans and Berg.
Studies on SV40 also played a major role in
the genetic engineering revolution and the
birth of the biotechnology industry.
THE FIRST SEQUENCING
SUCCESSES
Prior to the use of restriction endonucle-
ases, sequencing studies were largely limited
to the handful of bases at the very ends of
viral genomes (a striking limitation in the
case of circular genomes). Now the entire
viral genome was accessible.
Theinitiallarge-scalesequencingefforts
bore fruit in 1977 with the publication of the
completeDNAsequenceofφX174byacon-
sortiumheadedbyFrederickSanger(whoal-
ready had won a Nobel Prize for developing
methods to sequence proteins and later won
a second Nobel for DNAsequencing) [6].
The next year, the DNAsequence of the
tumor virus SV40 was solved by groups
headed by Sherman Weissman at Yale Uni-
versity and Walter Fiers in Belgium [7-8].
φX174 and SV40 are relatively simple
viruses, each with only about 5,000 DNA
base pairs (compared to the 6 billion base
pairs in each of our cells), but with the prim-
itive methods available at that time, this se-
quence analysis required many years and
prodigious effort. With today’s technology,
the genomes of these small viruses can be
knocked off in a busy afternoon.
VIRUSES TAKE CENTER STAGE
With the support of the “War on Can-
cer” declared by the National Cancer Insti-
tute in the 1970s, tumor virologists rapidly
adopted sequencing as a primary method to
analyze viral genomes, and larger DNA
tumor viruses soon fell to sequencing ef-
forts: papillomaviruses, the cause of warts
and cervical and some other human cancer,
with 8,000 base pairs, in 1982; and aden-
oviruses, which cause respiratory tract dis-
ease in humans and tumors in experimental
animals, with 36,000 base pairs, in 1984.
The following year, 1985, saw the comple-
tion of the 172,000 base pair sequence of the
DNA of Epstein-Barr virus, a herpesvirus
that infects virtually all humans and causes
certain infected individuals to develop
Hodgkin’s disease, Burkitt’s lymphoma, or
nasopharyngeal carcinoma. Since the se-
quencing was done manually, this heroic
feat required eight postdoctoral scientists
working full time for several years. The
poxviruses, a virus group that includes the
dreaded smallpox virus and related viruses
that can cause tumors in animals, weighed
in at 191,636 base pairs in 1990.
The necessity of sequencing and ana-
lyzing ever-larger viral genomes spurred im-
provements in technology. The first
sequences were derived from RNA copied
from the viral DNA, but researchers soon
moved to sequencing the DNAitself.Akey
breakthrough was the development of rapid
enzymatic DNA sequencing methods by
Sanger and colleagues at Cambridge Uni-
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chemical methods invented by Maxam and
Gilbert at Harvard University [10]. The
Cambridge group also developed “shot-gun”
methods for sequencing the genome of Ep-
stein-Barr virus, in which the sequence of
random fragments of viral DNA was deter-
mined, and the sequences of overlapping
DNA segments were then aligned by com-
puter.This method turned out to be essential
for solving the sequences of the much larger
bacterial and cellular genomes, and eventu-
ally the postdoctoral fellows were replaced
by robots for the cloning operations and by
automated DNA sequencing machines. Our
ability to record and analyze long DNA se-
quences was also sorely tested, a predica-
ment that helped lead to the development of
methods of computational analysis required
for the study of bacterial and cellular
genomes.
VIRAL GENOMES AS TARGETS
AND TEACHERS ABOUT
CANCER AND OTHER DISEASES
The sequences of viral genomes re-
vealed the great promise and limitations of
large-scale sequence analysis. For the first
time, the entire genetic legacy of an organ-
ism was manifest. Genes and regulatory sig-
nals were identified, protein structure and
function was deduced, and overall genetic
organization was laid bare. It seemed possi-
ble that a life form could be reduced to a set
of simple instructions, thus revealing its
most intimate secrets.
Novel human viruses were discovered
based on DNA sequencing; genes that
viruses captured from cellular DNA were
identified; and pathogenic mechanisms and
the genetic and evolutionary relationships
between different viruses were elucidated.
Again, studies of tumor viruses led the way.
Kaposi Sarcoma herpesvirus, which
commonly causes cancer in AIDS victims,
was discovered solely on the presence of
novel viral DNA sequences, related to Ep-
stein-Barr virus in a tumor [11], and hepati-
tis C virus was defined based on sequence
information [12,13]. Hepatitis C virus and
its compatriot hepatitis B virus are responsi-
ble for the development of hepatocellular
carcinoma, the third most common cancer in
the world [14,15]. Analysis of oncogenic
retroviruses isolated from animal tumors re-
vealed that these viruses carried genes re-
sponsible for cancer and that these genes
were actually altered versions of cellular
oncogenes [16], a discovery that won the
Nobel Prize for Michael Bishop and Harold
Varmus at the University of California at
San Franscisco. Extensive sequencing also
resulted in the identification of multiple dif-
ferent types of human papillomaviruses and
the discovery that certain high-risk HPV
types cause important human cancers
[17,18].
These studies ultimately led to develop-
ment of prophylactic vaccines designed to
prevent virus infection and the resulting
human cancers.Vaccines based on the major
capsid protein of the high-risk human papil-
lomaviruses will prevent much cervical can-
cer, and the hepatitis B virus surface antigen
vaccine already is causing a reduction in the
incidence of hepatocellular cancer [14,19].
These cancer vaccines are produced by
using recombinant DNA technology with
defined viral DNAsegments because of the
difficulty of propagating these human tumor
viruses in the laboratory.These two vaccines
alone have the potential to eliminate greater
than 10 percent of the world-wide cancer
burden.The prevention of cancers by vacci-
nation is the culmination of a century-long
effort to tie infectious agents to cancer and
validates this entire enterprise [20]. In addi-
tion, ongoing work at Yale and elsewhere
demonstrates that viral gene expression is
required to maintain the survival and growth
of certain cancers, suggesting that anti-viral
drugs may be useful in treating these cancers
once they develop [21,22,23]. Vaccination
against viral non-structural antigens ex-
pressed by cancer cells also has emerged as
a potential therapeutic approach.
Viruses responsible for acute infections
have been subjected to intense sequencing
efforts. Complete sequence information en-
abled the laboratory synthesis of infectious
poliovirus, a small virus that has so far
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In a remarkable example of molecular ar-
chaeology, sequencing of archived samples
of the 1918 pandemic influenza virus, which
caused the most deadly acute epidemic in
history, allowed the resurrection of this virus
[25]. Studies based on this work will have a
profound effect on our understanding of
these important human pathogens and the
genetic basis for future influenza pandemics,
but this work also inspired much discussion
about the potential misuse of sequence in-
formation and scientific knowledge. The
very rapid identification of a novel coron-
avirus as the causative agent of SARS was a
stunning achievement based entirely on se-
quencing [26,27]. Recent sequencing studies
also revealed that the environment harbors
a vast number of uncharacterized bacterio-
phage and other viruses [28,29]. Remark-
ably, the genes contained in these viruses
often do not resemble previously known
genes, hinting at immense genetic diversity
of viruses.
SURPRISES AND COMPLICATIONS
It was anticipated that genomic se-
quence information would lead to the rapid
elucidation of all the details of virus repro-
duction and myriad interactions between
viruses and cells and suggest new rational
approaches to combat virus infections and
virally induced tumors. But there also were
complications. Viruses were more clever,
versatile, and enigmatic than we appreci-
ated, and not all their secrets were revealed
by simple sequence analysis alone. RNA
splicing, first discovered in oncogenic ade-
noviruses and widespread in cellular genes
as well [30,31], results in the synthesis of
proteins assembled from segments encoded
by DNA scattered about the genome, com-
plicating efforts to deduce protein sequence
from DNAsequence.
In other cases, viruses selectively ig-
nored signals that should tell the cellular ma-
chinery where genes started and stopped,
and RNAediting or ribosomal frameshifting
confounded the definition of a gene (e.g.,
[32,33]). One of the first viral sequences
solved revealed the startling situation that
the same piece of DNA could encode two
proteins with entirely different amino acid
sequences [34]. Thus, it became clear that
complete understanding of an organism,
even one as simple as a virus, cannot be de-
duced from sequence information alone, but
the services of experimental biologists were
still needed.
MOVING BEYOND VIRUSES
The great value of sequencing was im-
mediately clear to the scientific community
and inspired successful attempts to decipher
larger cellular genomes.
The first complete DNA sequence of a
bacterial genome, that of Mycoplasma gen-
italium, was reported in 1995 [35], and now
hundreds of bacterial genomes have been
decoded, providing valuable information
about the lifestyle, evolution, and pathogen-
esis of these organisms.And in 2001, the en-
tire human genome sequence was
completed.
In parallel, the genomes of several other
pathogens and organisms useful as experi-
mental models, including the malaria para-
site, insects, worms, plants, and other
mammals, have been sequenced. These se-
quences uncovered a treasure trove of infor-
mation that is revolutionizing our
understanding of evolution, gene organiza-
tion and function, cellular function, devel-
opment, and disease. These studies also
revealed the disquieting fact that a substan-
tial fraction of our own genomes is derived
from remnants of viruses related to onco-
genic retroviruses. It has even been postu-
lated that the transfer of viral genes into
primordial RNA-based cells gave rise to the
three branches of cellular life on earth: bac-
teria, archea, and eukaryotes [36].
MORE INSIGHTS INTO CANCER
DNAsequencing has had a particularly
profound effect on our understanding of car-
cinogenesis and on efforts to control this dis-
ease. Sequencing of the cellular versions of
the oncogenes first identified in tumor
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many sporadically occurring human cancers
[37], helping to establish the notion that
much of cancer has a genetic basis.
Many of these oncogenes encode
growth factors, growth factor receptors, sig-
nal transduction proteins, and transcription
factors, which are crucial components of
signaling pathways that determine how cells
respond to their environment, grow, and die.
Based on these and related studies, it is now
possible in some cases to predict a patient’s
prognosis or response to chemotherapy
based on the sequence of cellular proteins
involved in cell signaling and growth [38].
The elucidation of the human genome
sequence also allowed the construction of
microarrays that have been used to assess
the transcriptional profile of normal and can-
cer cells. These studies revealed the exis-
tence of subsets of various tumors with
markedly different prognosis, suggesting
underlying biological differences that can be
exploited in developing improved ap-
proaches for managing these diseases [39].
In addition, advances in rapid sequenc-
ing and computational analysis allowed
comprehensive comparison of the sequences
of normal and cancer cell genomes and the
identification of crucial shared mutations in
independently arising cancers [40]. The
genes identified in this manner are likely to
play important roles in carcinogenesis and
provide new targets for therapy and diagno-
sis.
Sequencing of DNAisolated from can-
cers also revealed the frequent occurrence of
mutations in genes encoding tumor suppres-
sor proteins, particularly p53, which was
first identified as a binding partner of SV40
large T antigen, the viral DNA replication
protein [41,42]. Large T antigen also binds
the retinoblastoma tumor suppressor protein,
a central component of another tumor sup-
pressor pathway often inactivated by muta-
tion in human cancers [43]. Strikingly, three
unrelated groups of DNA tumor viruses,
SV40, human papillomaviruses, and aden-
oviruses, all inactivate these same tumor
suppressor proteins, implying the existence
of a limited number of regulatory nodes es-
sential for viral replication and cellular car-
cinogenesis.
These important cellular genomics ef-
forts clearly had their origins in studies of
viral genomes. Francis Collins, who heads
the National Human Genome Research In-
stitute and directed the United States’effort
to sequence the human genome, was trained
in the Weissman laboratory at Yale that se-
quenced SV40. Two of the prime movers of
the landmark 1995 M. genitalium sequence
were Hamilton Smith and Craig Venter.
Smith and his Johns Hopkins’ colleague
Nathans supplied essential information and
materials for the SV40 sequencing project,
and a year before the appearance of the first
complete bacterial sequence, Venter pub-
lished the sequence of smallpox virus DNA.
The ability to decode bacterial and cel-
lular genomes is a watershed achievement in
biology,onethatistransformingourconcepts
of microbial pathogenesis, cellular function,
evolution, and human disease, particularly
cancer. This remarkable accomplishment is
the logical extension of pioneering studies
begun a quarter of a century earlier on
viruses, the simplest organisms at the border
between chemistry and life.
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